Michael Woudenberg

Overview

Michael Woudenberg received an average of $326K in total compensation, including $271K in salary, at InMed Pharmaceuticals from 2022 to 2024.

Source: SEC filings on October 28, 2024 and October 27, 2023.

Related executives

We found six more executives who work or worked at InMed Pharmaceuticals.

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

Eric Hsu

InMed Pharmaceuticals

Senior Vice President, Preclinical Research & Development

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

Netta Jagpal

InMed Pharmaceuticals

Chief Financial Officer

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

Bruce Colwill

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like